Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers Put Squeeze on Cells to Deliver

23.07.2013
Imagine being able to redirect powerful immune cells to fight cancer. How about reprogramming a diabetic’s skin cell into a cell that could manufacture the insulin their pancreas no longer produces? Could we dial down the production of fat cells in obese adolescents?

These are major health problems and medical challenges that may be more achievable with a new fundamental technology that gets vital control molecules into cells faster, safer, and more effectively.

NIBIB-funded engineers at the Massachusetts Institute of Technology (MIT) have developed a rapid and highly efficient system for transferring large molecules, nanoparticles, and other agents into living cells, providing new avenues for disease research and treatment. Cells carrying these “transferred molecules”– the intended therapy - can be used in many ways, including therapeutic and diagnostic interventions in patients and experimental therapies in animal models of disease.

The technique offers a powerful tool for probing how cells and their molecular components work by studying how transferred molecules affect a cell’s behavior and functions.

The system uses controlled mechanical force (relatively gentle squeezing) that is non-toxic to cells, unlike other methods that use viruses, chemicals or electric shock, which can kill cells and damage the transferred molecules. In addition, the new device is “high throughput,” which means it works rapidly, treating a remarkable 20,000-100,000 cells per second.

The speedy transfer of therapeutic molecules into cells with minimal cell damage and death allows millions of cells to be treated in a very short period of time. This is important because usually, large numbers of treated cells are needed to achieve diagnostic and therapeutic effects.

The system was developed through a collaboration between the laboratories of Robert Langer and Klavs Jensen, both at MIT. The work is published in the February 5 edition of the Proceedings of the National Academies of Science.

How it works

The device, known as a microfluidic delivery platform, is made up of channels etched into a silicon microchip through which cells initially can flow freely. However, as the cells move through the device --like an inner tube along a water slide-- the channel width narrows until a cell finds itself in a tight spot -- forced to fit through a space that is narrower than the cell. The supple cell membrane allows the cell to squeeze through the constriction. However, the forced, rapid change in cell shape creates temporary holes in the cell membrane, without permanently damaging or killing the cell.

While the cell membrane is temporarily disrupted, the molecules to be delivered pass through the holes in the membrane and enter the cell. As the cell rebounds to its normal shape, the holes in the membrane close; the cell is loaded successfully. Virtually any type of molecule can be delivered into large numbers of any type of cell.

New technique expands experimental and therapeutic possibilities

The new system has distinct advantages over those currently in use. For example, a common technique known as electroporation cannot successfully deliver nanoparticles because they get damaged or inactivated by the electric pulse that is applied to disrupt the cell membrane. Two such nanoparticles are quantum dots and gold nanoparticles, which can be used to track cells inside the body because their electrical properties make them highly visible using biological imaging techniques. Using the new MIT technique, which disrupts the cell membrane by mechanical force rather than an electrical pulse, the team successfully transferred these nanoparticles without damaging their electrical properties. Therefore, the new technique allows researchers to load these electrically sensitive nanoparticles into cells and follow them through the body to diagnose disease and monitor treatments.

Another significant advantage of the relatively gentle, yet highly effective technique is the ability to transfer molecules into fragile cells that do not survive the current methods. One such cell type is skin cells taken directly from an individual. Using the new mechanical force system the team successfully transferred a set of proteins into freshly obtained human skin cells, where the proteins acted to transform the skin cells into stem cells. Stem cells are an “all purpose” type of cell that scientists are eagerly working with to develop new regenerative therapies. The ability to easily make stem cells from an individual’s skin cells, using this new technique, is a significant step that promises to accelerate the development of stem cell based therapies to regenerate diseased or damaged tissues.

Some of the most exciting uses for this new system are likely to take the form of novel therapies. Armon Sharei, a graduate student in the Jensen laboratory and one of the lead developers of the technique, described a therapeutic application that the researchers are particularly excited about: “Our big push today is in the field of immunology. Immune cells are very resistant to traditional transfer techniques, yet they hold enormous therapeutic potential. In close collaboration with other laboratories, we hope to use this technology to harness the power of the patient’s own immune system to combat complex immune disorders that currently have no effective treatments.”

The project was supported partially by an American Recovery and Reinvestment Act (ARRA) NIH Challenge Grant. The special two-year grants supported research on Challenge Topics that addressed specific scientific and health research challenges in biomedical and behavioral research. Dr. Rosemarie Hunziker, the NIBIB Program Director for Tissue Engineering and Regenerative Medicine elaborates: “The goal of the ARRA awards was to support studies that could produce important innovations within a short time frame. We certainly achieved that here. This deceptively simple new way to control cell behavior offers exciting promise for studies of basic cell biology as well as enabling cell-based therapies previously only envisioned. Now that the basic principle has been established here, numerous novel applications can be pursued by diverse teams of scientists and engineers. It’s what we do at NIBIB--enable technologies capable of making a profound difference in medical care and the lives of patients.”

-- Tom Johnson

This work was funded by the National Institute of Biomedical Imaging and Bioengineering with additional support from the National Institute of Craniofacial and Dental Research and the National Cancer Institute

Margot Kern | Newswise
Further information:
http://www.nih.gov

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>